Mannose binding lectin deficiency and triglyceride-rich lipoprotein metabolism in normolipidemic subjects

Atherosclerosis

Volumn 206, Issue 2, 2009, Pages 444-450

  Alipour, A ^a,b   van Oostrom, A J H H M ^c   Van Wijk, J P H ^b   Verseyden, C ^b   Plokker, H W M ^c   Jukema, J W ^d   Rabelink, A J ^d   Castro Cabezas, M ^a,b  

^a SINT FRANCISCUS GASTHUIS   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; Complement; Postprandial lipemia; Triglyceride rich lipoproteins

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; COMPLEMENT COMPONENT C3; FATTY ACID; HYDROXYBUTYRIC ACID; LIPOPROTEIN; MANNOSE BINDING LECTIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; OBSERVATIONAL STUDY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION;

ADULT; DIETARY FATS; FEMALE; HUMANS; LIPOPROTEINS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 70349432358     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.03.007     Document Type: Article

References (39)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1990) 115-126
2. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
3. Walport M.J. Complement: first of two parts. N Engl J Med 344 (2001) 1058-1065
4. Best L.G., Davidson M., North K.E., et al. Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians. Circulation 109 (2004) 471-475
5. Madsen H.O., Videm V., Svejgaard A., Svennevig J.L., and Garred P. Association of mannose-binding lectin deficiency with severe atherosclerosis. The Lancet 352 (1998) 959-960
6. Hegele R.A., Ban M.R., Anderson C.M., and Spence J.D. Infection-susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area. J Invest Med 48 (2000) 198-202
7. Saevarsdottir S., Oskarsson O.O., Aspelund T., et al. Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk. J Exp Med 201 (2005) 117-125
8. Ohlenschlaeger T., Garred P., Madsen H.O., and Jacobsen S. Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 351 (2004) 260-267
9. Biezeveld M.H., Kuipers I.M., Geissler J., et al. Association of mannose-binding lectin genotype with cardiovascular abnormalities in Kawasaki disease. The Lancet 361 (2003) 1268-1270
10. Limnell V., Aittoniemi J., Vaarala O., et al. Association of mannan-binding lectin deficiency with venous bypass graft occlusions in patients with coronary heart disease. Cardiology 98 (2002) 123-126
11. Fiane A.E., Ueland T., Simonsen S., et al. Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation. Eur Heart J 26 (2005) 1660-1665
12. Cianflone K., Xia Z., and Chen L.Y. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta 1609 (2003) 127-143
13. Cianflone K.M., Sniderman A.D., Walsh M.J., Vu H.T., Gagnon J., and Rodriguez M.A. Purification and characterization of acylation stimulating protein. J Biol Chem 264 (1989) 426-430
14. Cianflone K., Maslowska M., and Sniderman A.D. Acylation stimulating protein (ASP), an adipocyte autocrine: new directions. Semin Cell Dev Biol 10 (1999) 31-41
15. Muscari A., Bozzoli C., Puddu G.M., et al. Association of serum C3 levels with the risk of myocardial infarction. Am J Med 98 (1995) 357-364
16. Van Oostrom A.J.H.H.M., Alipour A., Plokker H.W.M., Sniderman A.D., and Castro Cabezas M. The metabolic syndrome in relation to complement component 3 and postprandial lipemia in patients from an outpatient lipid clinic and healthy volunteers. Atherosclerosis 90 (2007) 167-173
17. Meijssen S., van Dijk H., Verseyden C., Erkelens D.W., and Castro Cabezas M. Delayed and exaggerated postprandial complement 3 response in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 22 (2002) 811-816
18. Engstrom G., Hedblad B., Eriksson K.F., Janzon L., and Lindgarde F. Complement C3 is a risk factor for the development of diabetes: a population-based cohort study. Diabetes 54 (2005) 570-575
19. Meilinger M., Gschwentner C., Burger I., et al. Metabolism of activated complement component C3 is mediated by the low density lipoprotein receptor-related protein/α2-macroglobulin receptor. J Biol Chem 274 (1999) 38091-38096
20. Scantlebury T., Maslowska M., and Cianflone K. Chylomicron-specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes. J Biol Chem 273 (1998) 20903-20909
21. Madsen H.O., Garred P., Thiel S., et al. Interplay between promotor and structural gene variants control basal serum level of mannan-binding protein. J Immunol 155 (1995) 3013-3020
22. Van Oostrom A.J.H.H.M., Sijmonsma T.P., Verseyden C., et al. Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J Lipid Res 44 (2003) 576-583
23. Karpe F., and Hamsten A. Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J Lipid Res 35 (1994) 1311-1317
24. Verseyden C., Meijssen S., and Castro Cabezas M. Effects of atorvastatin on fasting plasma and marginated apolipoproteins B48 and B100 in large, triglyceride-rich lipoproteins in familial combined hyperlipidemia. J Clin Endocrinol Metab 89 (2004) 5021-5029
25. Kuipers S., Aerts P.C., Sjöholm A.G., Harmsen Th, and van Dijk H. Hemolytic assay for the estimation of functional mannose-binding lectin levels in human serum. J. Immunol Methods 268 (2002) 149-157
26. Meijssen S., Castro Cabezas M., Twickler T.B., Jansen H., and Erkelens D.W. In vivo evidence of defective postprandial and postabsorptive free fatty acid metabolism in familial combined hyperlipidemia. J Lipid Res 41 (2000) 1096-1102
27. Zilversmit D.B. Atherogenesis: a postprandial phenomenon. Circulation 60 (1979) 473-485
28. Karpe F. Postprandial lipoprotein metabolism and atherosclerosis. J Int Med 246 (1999) 341-355
29. Genest J.J., McNamara J.R., Salem D.N., and Schaefer E.J. Prevalence of risk factors in men with premature coronary artery disease. Am J Cardiol 67 (1991) 1185-1189
30. Miller M., Seidler A., Moalemi A., and Pearson T.A. Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational long-Term Study. J Am Coll Cardiol 31 (1998) 1252-1257
31. Patsch J.R., Miesenböck G., Hopferwieser T., et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 12 (1992) 1336-1345
32. Weintraub M.S., Grosskopf I., Rassin T., et al. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. BMJ 312 (1996) 936-939
33. Lewis G.F., O'Meara N.M., Soltys P.A., et al. Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab 72 (1991) 934-944
34. Karpe F. Mechanisms of postprandial hyperlipidaemia-remnants and coronary artery disease. Diabet Med 14 Suppl. 3 (1997) S60-S66
35. Baggio G., Manzato E., Gabelli C., et al. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients. J Clin Invest 77 (1986) 520-527
36. Fredenrich A. Role of apolipoprotein CIII in triglyceride-rich lipoprotein metabolism. Diabetes Metab 24 (1998) 490-495
37. Schafranski M.D., Stier A., Nisihara R., and Messias-Reason I.J.T. Significantly increased levels of mannose-binding lectin (MBL) in rheumatic heart disease: a beneficial role for MBL deficiency. Clin Exp Immunol 138 (2004) 521-525
38. Vauhkonen M., Viitala J., Parkkinen J., and Rauvala H. High-mannose structure of apolipoprotein-B from low-density lipoproteins of human plasma. Eur J Biochem 152 (1985) 43-50
39. Vaisar T., Pennathur S., Green P.S., et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest 117 (2007) 746-756